Skip to main content
    N

    Neuropace Inc (NPCE)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $8.20
    +0.23 (+2.89%)

    Market Cap: $260.45M

    Last updated: Nov 17, 2026 at 4:30 PM ET

    Neuropace Inc (NPCE) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Neuropace (NPCE) has a latest price of $8.20 on Nov 17, 2026, 58.2% below its 52-week high of $19.60. Its price fell 36.6% over the past 12 months. The month-end price fell 18.9% over the 5 years through Oct 2026, a compound annual decline of 4.1%.

    Price Chart

    From Apr 2021 to Oct 2026, its highest month-end close was $24.16 in Apr 2021 and its lowest $1.49 in Dec 2022, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart NPCE with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NPCE.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 44.0%, and over 6 months it fell 48.3%. The month-end price rose 82.2% over the 3 years through Oct 2026, a compound annual rate of 22.1%.

    PeriodChange
    1 month-35.8%
    3 months-44.0%
    6 months-48.3%
    12 months-36.6%
    12 months, with dividends-36.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+82.2%+22.1%
    5 years-18.9%-4.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2023, when the price rose 591.9%, and its weakest was 2022, when it fell 85.2%.

    YearCloseChange
    2026 through Oct 2026$12.30-20.3%
    2025$15.44+38.0%
    2024$11.19+8.5%
    2023$10.31+591.9%
    2022$1.49-85.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 36.6% below its 50-day average of $12.94 and 44.2% below its 200-day average of $14.69.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$8.20
    52-week high$19.60-58.2%
    52-week low$5.46+50.2%
    50-day average$12.94-36.6%
    200-day average$14.69-44.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 66.3%.

    MeasureValue
    1-year beta1.35
    Largest fall, 1 year-60.8%
    Largest fall, 3 years-66.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About NPCE

    What is NPCE's 1-year price change?

    Neuropace's price fell 36.6% over the past 12 months. With dividends included, the 12-month total return was -36.6%.

    What is NPCE's 5-year price change?

    Neuropace's month-end price fell 18.9% over the 5 years through Oct 2026, a compound annual decline of 4.1%. These figures leave out dividends.

    What is NPCE's 52-week high and low?

    Neuropace's 52-week high is $19.60 and its 52-week low is $5.46. Its latest price of $8.20 on Nov 17, 2026 is 58.2% below the high.

    What is NPCE's beta?

    Neuropace's 1-year beta against the S&P 500 is 1.35, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 60.8%.

    Is the NPCE chart free?

    Yes. Advanced Charting for NPCE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.